Redmile Group reported a 5.6% stake in AgomAb Therapeutics AGMB · 2,735,926 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.6%
Last report: First report
Shares held: 2,735,926 sh
Class: Common Shares, no nominal value per share
Stock: AgomAb Therapeutics AGMB
Holder: Redmile Group
Event date: 26/03/31
Filed: 26/05/15

First 5%+ report · 5.6% stake

AgomAb Therapeutics trades, last 26 weeks

What else happened in AgomAb Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Redmile Group's other 5% stake reports

Redmile Group
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
8.7% stake
5,462,881 sh
8.7% stake
Filed 09/28
Redmile Group
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
8.1% stake
8,782,256 sh
8.1% stake
Filed 08/14
Redmile Group
5% stakeScholar Rock Holding
5% stake
Scholar Rock Holding
SRRK
3.6% stake
4,311,092 sh
3.6% stake
Filed 08/14
Redmile Group
5% stakeAtara Biotherapeutics
5% stake
Atara Biotherapeutics
ATRA
9.9% stake
950,994 sh
9.9% stake
Filed 07/24
Redmile Group
5% stakeShattuck Labs
5% stake
Shattuck Labs
STTK
9.9% stake
10,019,421 sh
9.9% stake
Filed 07/17